Orforglipron Topline Results & ADCES 2025 Part 1

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives · Aug 19, 2025 · 21m

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, share key insights and takeaways from the Association of Diabetes Care and Education Specialists (ADCES) 2025 annual meeting.00:00:00 Introduction00:00:25 Orforglipron and the ATTAIN-1 study00:01:29 Why orforglipron is exciting00:04:21 ADCES - Incredible Incretins00:10:33 ADCES - AI in diabetes management00:12:59 New AI tools for endocrinology00:19:01 ADCES - Implicit bias00:21:30 Closing